Fibrin-specific plasminogen activator TNKase (tenecteplase) is the first stroke medicine approved by the FDA in nearly 30 years, joining Roche/Genentech's Activase (alteplase), which is the only ...

Alteplase (Activase, Genentech) was prepared in 1-mL portions at a concentration of 1 mg/mL from 50-mg alteplase vials in the pharmacy and stored in the pharmacy in a constant temperature freezer ...

Genentech is letting go of 143 employees who are based out of the company's headquarters in South San Francisco. The workforce reduction will be complete by July 14, according to a California ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III IMforte study of Tecentriq® (atezoliz ...

SOUTH SAN FRANCISCO, Calif., June 02, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III IMforte study of Tecentriq ...

SOUTH SAN FRANCISCO, Calif., May 30, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new, 96-week data for fenebrutinib demonstrating that patients with ...

According to Genentech, the partnership will help to transform its GenAI models and algorithms into a “next-generation AI platform” operating at the interface between biology and computation.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Ph ...

On ASCO Day 3, AstraZeneca is dominant (again), Protagonist Therapeutics and Takeda review blood cancer data, and more.

Biotechnology company Genentech announced plans to build its first East Coast manufacturing facility in Holly Springs, North Carolina. With an initial investment of over $700 million, the 700,000 ...

Instill 1 mL of alteplase 0.5 mg/mL into the catheter. If the catheter has a capacity of >1 mL, follow the alteplase with 0.9% sodium chloride injection. Allow the solution to dwell for 60 minutes.